Genetic & Genomic MedicineBrain Behavior & Immunity - HealthPeer-reviewed
Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a pQTL-based Mendelian randomization and colocalization analysis
Christina N. Kushnir, Victoria Taylor‐Bateman, Neil M Davies, Emma Louise Anderson
This study uses pQTL-based Mendelian randomization and colocalization to assess if DMARD targets reduce Alzheimer's disease risk, finding only FCGR3B shows increased risk with higher plasma levels.